KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Change in Receivables: 2009-2024

Historic Change in Receivables for Arbutus Biopharma (ABUS) over the last 16 years, with Dec 2024 value amounting to $633,000.

  • Arbutus Biopharma's Change in Receivables rose 24.53% to -$120,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$703,000, marking a year-over-year decrease of 24.87%. This contributed to the annual value of $633,000 for FY2024, which is 49.29% up from last year.
  • As of FY2024, Arbutus Biopharma's Change in Receivables stood at $633,000, which was up 49.29% from $424,000 recorded in FY2023.
  • Arbutus Biopharma's 5-year Change in Receivables high stood at $633,000 for FY2024, and its period low was -$413,000 during FY2021.
  • Over the past 3 years, Arbutus Biopharma's median Change in Receivables value was $453,000 (recorded in 2022), while the average stood at $503,333.
  • In the last 5 years, Arbutus Biopharma's Change in Receivables plummeted by 482.41% in 2021 and then soared by 209.69% in 2022.
  • Over the past 5 years, Arbutus Biopharma's Change in Receivables (Yearly) stood at $108,000 in 2020, then plummeted by 482.41% to -$413,000 in 2021, then surged by 209.69% to $453,000 in 2022, then dropped by 6.40% to $424,000 in 2023, then surged by 49.29% to $633,000 in 2024.